Company Filing History:
Years Active: 2014
Title: Hervé Abry: Innovator in Automatic Injection Technology
Introduction
Hervé Abry, an adept inventor based in Champagnier, France, has made significant contributions to the field of automatic injection devices. With a patent to his name, he has focused on creating innovative solutions for effective and safe medication administration.
Latest Patents
Hervé Abry holds a noteworthy patent titled "Autoinjector with Deshielder Comprising Tamper Evidence Means." This invention relates to a device designed for the automatic injection of a product into an injection site. The autoinjector features a needle along with a protective needle shield that safeguards the needle prior to use. The housing of the device accommodates a container and a deshielder responsible for removing the needle shield. Notably, the deshielder is coupled to the needle shield and is mounted on the housing in a separable manner, allowing for easy operation. It includes tamper evidence mechanisms activated by the removal of parts of the deshielder, ensuring added safety and reliability during use. The device is engineered to allow the removal of at least one part of the deshielder through a minimal exertion of force, equal to or less than 30 N.
Career Highlights
Hervé Abry is affiliated with Becton Dickinson France, a renowned company specialized in medical devices and technology. His work here has centered around developing innovations that enhance patient care through efficient drug delivery systems.
Collaborations
Throughout his career, Hervé has collaborated with talented professionals, including David Llewellyn-Hyde and Vernon Rich. These collaborations have fostered an environment of creativity and innovation, allowing for the development of cutting-edge medical devices.
Conclusion
Hervé Abry stands out as an influential inventor in the medical technology sector. His patented autoinjector with advanced tamper evidence features marks a significant advancement in the safe administration of medication. As he continues to work at Becton Dickinson France, his contributions will undoubtedly pave the way for future innovations in healthcare technology.